Aiea, Hawaii
Hawaii Biotech, Inc. (HBI) is a privately held biotechnology company focused on the research and development of vaccines for established and emerging infectious diseases. The company has developed a proprietary protein production platform that is applicable to the production of vaccine antigens. The company’s lead vaccine candidates target the West Nile virus and the viruses responsible for seasonal influenza. A dengue vaccine is also under development for individuals traveling to or living in dengue endemic areas.